Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Access to Document

@article{cd923725c54e4a008e1030f188f9d4d8,

title = "Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding",

author = "{de Lange}, {Maria E.} and Huirne, {Judith A. F.}",

year = "2022",

month = sep,

day = "17",

doi = "https://doi.org/10.1016/S0140-6736(22)01781-0",

language = "English",

volume = "400",

pages = "866--867",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10356",

}

TY - JOUR

T1 - Linzagolix

T2 - an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding

AU - de Lange, Maria E.

AU - Huirne, Judith A. F.

PY - 2022/9/17

Y1 - 2022/9/17

UR - http://www.scopus.com/inward/record.url?scp=85138014505&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S0140-6736(22)01781-0

DO - https://doi.org/10.1016/S0140-6736(22)01781-0

M3 - Comment/Letter to the editor

C2 - 36116467

SN - 0140-6736

VL - 400

SP - 866

EP - 867

JO - The Lancet

JF - The Lancet

IS - 10356

ER -